NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 446 filers reported holding NOVAVAX INC in Q3 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,155 | -2.6% | 712 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $5,290 | +7.2% | 712 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $4,934 | -32.6% | 712 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $7,319 | -43.7% | 712 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $13,000 | -64.9% | 712 | 0.0% | 0.00% | -66.7% |
| Q2 2022 | $37,000 | -28.8% | 712 | 0.0% | 0.01% | -14.3% |
| Q1 2022 | $52,000 | -49.0% | 712 | 0.0% | 0.01% | -46.2% |
| Q4 2021 | $102,000 | -43.0% | 712 | -17.4% | 0.01% | -45.8% |
| Q3 2021 | $179,000 | -2.2% | 862 | 0.0% | 0.02% | -4.0% |
| Q2 2021 | $183,000 | +41.9% | 862 | +21.1% | 0.02% | +31.6% |
| Q1 2021 | $129,000 | +63.3% | 712 | 0.0% | 0.02% | +46.2% |
| Q4 2020 | $79,000 | +83.7% | 712 | +80.3% | 0.01% | +62.5% |
| Q3 2020 | $43,000 | +230.8% | 395 | +163.3% | 0.01% | +166.7% |
| Q2 2020 | $13,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $18,549,000 | 4.18% |
| OPTIMAS CAPITAL Ltd | 27,800 | $2,047,000 | 1.92% |
| RA Capital Management | 692,794 | $51,024,000 | 1.11% |
| Mendel Capital Management LLC | 13,689 | $1,008,000 | 0.95% |
| Rock Springs Capital Management LP | 448,200 | $33,010,000 | 0.83% |
| SECTORAL ASSET MANAGEMENT INC | 50,500 | $3,719,000 | 0.66% |
| TOBAM | 173,685 | $12,792,000 | 0.64% |
| SECTOR GAMMA AS | 38,324 | $2,823,000 | 0.61% |
| HAP Trading, LLC | 212,100 | $12,723,000 | 0.53% |
| Parametrica Management Ltd | 9,539 | $703,000 | 0.52% |